Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 5 | 2023 | 138 | 3.460 |
Why?
|
| Pregnancy | 24 | 2024 | 2202 | 2.380 |
Why?
|
| Pre-Eclampsia | 4 | 2024 | 69 | 2.370 |
Why?
|
| Cesarean Section | 4 | 2024 | 95 | 1.850 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2024 | 31 | 1.840 |
Why?
|
| Hypoglycemia | 2 | 2023 | 66 | 1.520 |
Why?
|
| Prediabetic State | 2 | 2022 | 51 | 1.500 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 88 | 1.460 |
Why?
|
| Obstetric Labor Complications | 2 | 2021 | 24 | 1.350 |
Why?
|
| Retrospective Studies | 18 | 2024 | 6071 | 1.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 605 | 1.120 |
Why?
|
| Infant, Newborn | 9 | 2024 | 1283 | 0.990 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 635 | 0.970 |
Why?
|
| Female | 26 | 2024 | 30705 | 0.930 |
Why?
|
| Labor, Obstetric | 2 | 2023 | 38 | 0.910 |
Why?
|
| Heart Diseases | 2 | 2024 | 206 | 0.900 |
Why?
|
| Stillbirth | 1 | 2023 | 17 | 0.870 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 38 | 0.850 |
Why?
|
| Labor Presentation | 1 | 2023 | 3 | 0.850 |
Why?
|
| Aneuploidy | 1 | 2023 | 40 | 0.850 |
Why?
|
| Dyspnea | 1 | 2024 | 116 | 0.850 |
Why?
|
| Cervical Ripening | 1 | 2023 | 10 | 0.840 |
Why?
|
| Chorioamnionitis | 2 | 2023 | 14 | 0.830 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2023 | 59 | 0.830 |
Why?
|
| Labor, Induced | 1 | 2023 | 25 | 0.820 |
Why?
|
| Genetic Testing | 1 | 2023 | 126 | 0.820 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 35 | 0.800 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 9 | 0.770 |
Why?
|
| Postpartum Period | 3 | 2023 | 182 | 0.770 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 11 | 0.760 |
Why?
|
| Insulins | 1 | 2021 | 15 | 0.750 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 114 | 0.740 |
Why?
|
| Hysterotomy | 1 | 2021 | 1 | 0.730 |
Why?
|
| Uterine Rupture | 1 | 2021 | 6 | 0.730 |
Why?
|
| Echocardiography | 1 | 2024 | 457 | 0.720 |
Why?
|
| Blood Glucose | 4 | 2023 | 461 | 0.680 |
Why?
|
| Humans | 26 | 2024 | 59360 | 0.640 |
Why?
|
| Vaginal Neoplasms | 1 | 2018 | 3 | 0.620 |
Why?
|
| Perineum | 1 | 2018 | 19 | 0.620 |
Why?
|
| Lacerations | 1 | 2018 | 16 | 0.620 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 14 | 0.620 |
Why?
|
| Menorrhagia | 1 | 2018 | 17 | 0.610 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 60 | 0.610 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 83 | 0.600 |
Why?
|
| Bacteremia | 1 | 2019 | 91 | 0.580 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 57 | 0.580 |
Why?
|
| Adult | 13 | 2024 | 15669 | 0.560 |
Why?
|
| Pregnant Women | 3 | 2022 | 84 | 0.530 |
Why?
|
| Pregnancy Outcome | 3 | 2023 | 181 | 0.530 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 29 | 0.520 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 23 | 0.520 |
Why?
|
| Risk Factors | 6 | 2024 | 4984 | 0.510 |
Why?
|
| Contraception Behavior | 1 | 2016 | 35 | 0.500 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 788 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 735 | 0.480 |
Why?
|
| Logistic Models | 4 | 2024 | 1232 | 0.480 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2024 | 145 | 0.380 |
Why?
|
| Peripartum Period | 2 | 2024 | 21 | 0.380 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 364 | 0.380 |
Why?
|
| Parturition | 2 | 2021 | 51 | 0.370 |
Why?
|
| United States | 5 | 2023 | 7390 | 0.350 |
Why?
|
| Hypoglycemic Agents | 2 | 2023 | 192 | 0.350 |
Why?
|
| Glucose | 2 | 2023 | 445 | 0.330 |
Why?
|
| Parity | 2 | 2023 | 70 | 0.330 |
Why?
|
| Contraception | 2 | 2022 | 67 | 0.310 |
Why?
|
| Insulin | 2 | 2023 | 674 | 0.300 |
Why?
|
| Infant | 2 | 2023 | 1486 | 0.280 |
Why?
|
| Delivery, Obstetric | 2 | 2018 | 51 | 0.270 |
Why?
|
| Young Adult | 3 | 2023 | 4267 | 0.250 |
Why?
|
| Heart Failure | 2 | 2024 | 853 | 0.240 |
Why?
|
| Pericardial Effusion | 1 | 2024 | 16 | 0.220 |
Why?
|
| Adolescent | 3 | 2021 | 5824 | 0.220 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2023 | 12 | 0.210 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 94 | 0.210 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 164 | 0.210 |
Why?
|
| Heart Valve Diseases | 1 | 2024 | 88 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2024 | 2374 | 0.210 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 53 | 0.210 |
Why?
|
| Gestational Age | 1 | 2023 | 178 | 0.200 |
Why?
|
| Carbohydrates | 1 | 2022 | 39 | 0.200 |
Why?
|
| Acculturation | 1 | 2022 | 33 | 0.200 |
Why?
|
| Contraceptive Effectiveness | 1 | 2022 | 3 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 119 | 0.200 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 162 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 155 | 0.190 |
Why?
|
| Early Diagnosis | 1 | 2021 | 92 | 0.180 |
Why?
|
| Trial of Labor | 1 | 2021 | 7 | 0.180 |
Why?
|
| Electrocardiography | 1 | 2024 | 523 | 0.180 |
Why?
|
| Preconception Care | 1 | 2021 | 23 | 0.180 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 674 | 0.170 |
Why?
|
| Odds Ratio | 1 | 2021 | 745 | 0.160 |
Why?
|
| Heart Arrest | 1 | 2021 | 161 | 0.160 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 4 | 0.160 |
Why?
|
| Laparoscopy | 1 | 2023 | 427 | 0.160 |
Why?
|
| Uterine Diseases | 1 | 2019 | 9 | 0.160 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 14 | 0.160 |
Why?
|
| Extraction, Obstetrical | 1 | 2018 | 1 | 0.160 |
Why?
|
| Episiotomy | 1 | 2018 | 2 | 0.160 |
Why?
|
| Diet | 1 | 2022 | 497 | 0.150 |
Why?
|
| Fever | 1 | 2019 | 63 | 0.150 |
Why?
|
| Narcotics | 1 | 2018 | 50 | 0.150 |
Why?
|
| Counseling | 1 | 2021 | 349 | 0.150 |
Why?
|
| Pelvis | 1 | 2018 | 58 | 0.150 |
Why?
|
| Vagina | 1 | 2018 | 79 | 0.150 |
Why?
|
| Boston | 1 | 2018 | 246 | 0.150 |
Why?
|
| Prenatal Care | 1 | 2019 | 169 | 0.140 |
Why?
|
| Gravidity | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2373 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2018 | 459 | 0.130 |
Why?
|
| Abortion, Induced | 1 | 2016 | 23 | 0.130 |
Why?
|
| Exercise | 1 | 2022 | 883 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 406 | 0.120 |
Why?
|
| Hospitalization | 1 | 2021 | 1290 | 0.110 |
Why?
|
| Obesity | 1 | 2021 | 1166 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1127 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1099 | 0.100 |
Why?
|
| Child | 1 | 2021 | 4174 | 0.090 |
Why?
|
| Abruptio Placentae | 1 | 2024 | 2 | 0.060 |
Why?
|
| Umbilical Arteries | 1 | 2024 | 9 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2024 | 34 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2024 | 70 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 76 | 0.060 |
Why?
|
| ROC Curve | 1 | 2024 | 266 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 55 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2023 | 65 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 98 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 300 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2023 | 1051 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 326 | 0.040 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 5 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 51 | 0.040 |
Why?
|
| Time Factors | 1 | 2024 | 3617 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1093 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1237 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 705 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Middle Aged | 1 | 2024 | 16317 | 0.020 |
Why?
|